News
RBGLY
11.36
+1.97%
0.22
Weekly Report: what happened at RBGLY last week (0318-0322)?
Weekly Report · 3d ago
Market Talk Roundup: Reckitt Benckiser's Shares Bounce Back After Major Selloff
Reckitt Benckiser is the FTSE 100 bluechip index's top performer, with shares up 2.7%. Shares bounced back from a 15% drop on Friday after a jury sided with a plaintiff in a case relating to its Enfamil infant formula. Barclays Capital says Reckitt's share drop looks like a substantial over-reaction. The company faces uncertain levels of risk from litigation concerning its U.S. Infant formula, analysts say.
Dow Jones · 03/18 14:03
Weekly Report: what happened at RBGLY last week (0311-0315)?
Weekly Report · 03/18 11:37
Enfamil maker vows to fight $60 million baby-formula verdict
MarketWatch · 03/15 19:02
What's Going On With Abbott Laboratories Stock On Friday?
Illinois jury finds Mead Johnson to pay $60 million to mother of premature infant who died from NEC. Hundreds of similar lawsuits are pending against Mead Johnson and Abbott Laboratories Inc. The jury found Mead Johnson negligent for failing to warn of the risks associated with NEC. The verdict signifies the opening of a legal floodgate.
Benzinga · 03/15 17:48
Reckitt Benckiser Sheds Nearly $7 Billion in Market Value After Infant-Formula Verdict -- Update
London-listed shares in Reckitt Benckiser closed nearly 15% lower on Friday. The U.K. Consumer-goods company lost almost $7 billion in market value. An Illinois jury ordered the company's infant-formula unit to pay $60 million in compensation. The jury sided with a plaintiff in a case relating to a premature baby's death.
Dow Jones · 03/15 17:48
Abbott falls after setback to Reckitt Benckiser in baby formula case
Abbott falls after setback to Reckitt Benckiser in baby formula case. A jury ordered Mead Johnson to pay $60M over claims that a premature child died after consuming Enfamil baby formula. Abbott (ABT) has lost 4%, marking its biggest intraday drop in five months.
Seeking Alpha · 03/15 16:09
Reckitt Benckiser Shares Plunge After Infant-Formula Verdict
Reckitt Benckiser shares fall 17% after a jury sided with a plaintiff in a case relating to infant-formula Enfamil. The U.K. Consumer-goods company's stock is on track for its worst one-day percentage fall ever. The company says it strongly disagrees with the jury's decision.
Dow Jones · 03/15 16:06
Walgreens settles with New York over price gauging on baby formula
Healthcare Walgreens settles with New York over price gauging on baby formula. Pharmacy chain operator allegedly inflated prices on at least 20 baby formula products amid a nationwide shortage in 2022. Walgreen's will pay $50K to cover costs and donate formula to low-income New Yorkers.
Seeking Alpha · 03/12 11:13
International Wide-Moat Stocks On Sale - The March 2024 Heat Map
Home Stock Ideas Quick Picks & Lists International Wide-Moat Stocks On Sale - The March 2024 Heat Map. As of March 9, there were 79 international wide-moat stocks meeting Morningstar's criteria. Only 11.4% of these stocks earned a 5-star valuation rating.
Seeking Alpha · 03/11 12:22
Weekly Report: what happened at RBGLY last week (0304-0308)?
Weekly Report · 03/11 11:33
Estée Lauder, Reckitt fall amid cancer risk in acne treatments
Shares of Estée Lauder, Reckitt fall amid cancer risk in acne treatments. Independent U.S. Lab says it found high levels of cancer-causing chemical benzene in some of the companies' treatments. The chemical can cause leukemia in high amounts. Estee Lauder and Reckitt both lost 2% in pre-market trading.
Seeking Alpha · 03/06 13:44
Weekly Report: what happened at RBGLY last week (0226-0301)?
Weekly Report · 03/04 11:37
Durex Owner Reckitt Benckiser Taps Into China's Livestreaming Trend To Sell Condoms Online
Reckitt Benckiser Group is testing the waters of livestreaming as a sales channel for condoms in China. The company is hoping to expand its share of the $5 billion-plus condom market in the country. Livestreaming has been a driving force behind the e-commerce boom in China, generating sales of $238 billion.
Benzinga · 02/29 07:54
Correction to Lysol Maker Reckitt Benckiser Is Running Out of Excuses Article
Unilever reported results on Feb. 8, and Reckitt's big share price move was on Tuesday, not Wednesday. A previous version of this article gave incorrect dates for Reckitt Benckiser's results. Unilever's results were on February 8, not February 7.
Dow Jones · 02/28 19:24
Lysol Maker Reckitt Benckiser Is Running Out of Excuses
Reckitt Benckiser said comparable sales fell 1.2% from a year earlier. Underlying volumes declined 4.3%. The company attributed weakness in the health division to the cold and flu season. Unilever reported comparable sales growth of 4.7% in the fourth quarter.
The Wall Street Journal · 02/28 17:05
Weekly Report: what happened at RBGLY last week (0219-0223)?
Weekly Report · 02/26 11:52
Weekly Report: what happened at RBGLY last week (0212-0216)?
Weekly Report · 02/19 11:54
Weekly Report: what happened at RBGLY last week (0205-0209)?
Weekly Report · 02/12 11:41
International Wide-Moat Stocks On Sale - The February 2024 Heat Map
Seeking Alpha · 02/09 07:51
More
Webull provides a variety of real-time RBGLY stock news. You can receive the latest news about Reckitt Benc through multiple platforms. This information may help you make smarter investment decisions.
About RBGLY
Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene, post-natal and home products. The Company's segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN). Health, Hygiene, Home and Portfolio Brands categories are split across the geographical segments of ENA and DVM. Its range of hygiene products includes disinfectant cleaners, automatic dishwashing detergents, pest control, depilatory products and acne treatments. The Company's portfolio of brands includes Durex, Mucinex, Scholl, Strepsils, Cillit Bang, Clearasil, Dettol, Harpic, Lysol, Mortein, Veet, Air Wick, Calgon, Queen V, Vanish and Woolite.